Area company helps North Carolina track COVID-19 medications

 
Posted11/16/2020 2:21 PM

BUFFALO GROVE -- ARxIUM, a provider of pharmacy automation, workflow and inventory management solutions, said it has completed a multiyear engagement that expands and integrates the UNC Health Shared Services Center, UNC Hospitals, and Rex Hospital.

UNC Health is an integrated health care system owned by the state of North Carolina and based in Chapel Hill.

                                                                                                                                                                                                                       
 

UNC Health's use of RxWorks Pro, an inventory management application, has been instrumental during COVID-19 in providing readily available data, ARxIUM said. It has allowed the informatics department to remotely access RxWorks, enabling the health system to share data for specific medications, such as remdesivir. Additionally, the application's Virtual Location feature helps manage COVID-related medication inventory across all UNC facilities and provides real time tracking and optimization of locations with the highest demand.

"As a long-standing, collaborative partner with UNC Health, completing the expansion and integration of their pharmacy operations is an exciting milestone for us," said Dr. Niels Erik Hansen, president and CEO of ARxIUM, which is based in Buffalo Grove and Winnipeg, Manitoba, Canada.

0 Comments
                                                                                                                                                                                                                       
 
Article Comments ()
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked. If a comment violates these standards or our terms of service, click the X in the upper right corner of the comment box. To find our more, read our FAQ.